Acetylarsenocholine: a cholinergic agonist

Area of Science:

• Pharmacology
• Neuroscience
• Toxicology

Background:

• Acetylcholine is a key neurotransmitter in the central and peripheral nervous systems.
• Understanding cholinergic ligand interactions is crucial for developing neurological treatments.
• Arsenic compounds can interfere with biological processes.

Purpose of the Study:

• To investigate the pharmacological properties of acetylarsenocholine, an arsenic analogue of acetylcholine.
• To determine the binding affinities of acetylarsenocholine to nicotinic and muscarinic receptors.
• To evaluate its agonistic activity at presynaptic muscarinic receptors.

Main Methods:

• Radioligand binding assays were used to determine dissociation constants (KD).
• Experiments were conducted on rat medulla-pons and cerebral cortex tissues.
• Functional assays were performed on guinea pig ileum myenteric plexus preparations.

Main Results:

• Acetylarsenocholine bound to nicotinic receptors (KD = 15 microM) in rat medulla-pons.
• Acetylarsenocholine bound to muscarinic receptors (KD = 10 microM) in rat cerebral cortex.
• It acted as an agonist at presynaptic muscarinic receptors in the guinea pig ileum.

Conclusions:

• Acetylarsenocholine functions as a cholinergic ligand in both central and peripheral systems.
• It interacts with both nicotinic and muscarinic acetylcholine receptors.
• The study highlights the potential for arsenic-containing compounds to modulate cholinergic neurotransmission.